|
- An Expert’s Guide to ASCO 2025: Preview of the Top Abstracts | CCO
Experts highlight key studies being presented at the upcoming 2025 ASCO Annual Meeting CCO’s Independent Conference Coverage will include timely summaries and practical implications of the latest research and developments in oncology to help you stay at the forefront of advances in cancer care
- | CCO
Registration and Breakfast Coffee Talk with Key Opinion Leaders In-person learners are invited to start off the morning with key opinion leaders as well as other colleagues to enjoy coffee and informal discussions about a hot topic related to mood disorders
- Current events and curriculums for continuing medical education | CCO
View current list of medical professional events and course curriculums that can assist you in your continuing education Sign up online
- Content - 2025 ASCO GI | CCO - clinicaloptions. com
As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities
- Complexities in HER2+ MBC | CCO - clinicaloptions. com
As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities
- Asparaginase as the Cornerstone for ALL Chemotherapy | CCO
Certified on-demand webcast where an expert provides an overview of and rationale for asparaginase in the treatment of acute lymphoblastic leukemia, summarizes treatment outcomes in pediatric patients and adolescents and young adults, and compares pediatric and adult regimens
- Schizophrenia Treatment | CCO
As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities
- | CCO
Keynote Session: Do Obesity and Diabetes Mellitus Metastasize to the Brain? "Metaboptosis" and Implications for Potential Therapeutics in Psychiatry Presented by Roger S McIntyre, MD, FRCPC In this compelling session, we will explore the medical interface of GLP-1 agonists with psychiatric disorders including the neurobiological overlap of medical disorders and psychiatric disorders and the
|
|
|